RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BULFAMANTE S
Collezione AOU Città della Salute di Torino

Items : 8

In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens. in Frontiers in immunology / Front Immunol. 2024 Aug 8;15:1427424. doi: 10.3389/fimmu.2024.1427424. eCollection 2024.

2024
AOU Città della Salute di Torino

Cappello P; Giordano D; Campra D; Satolli MA; Spadi R; Genuardi E; Bonello L; Arigoni M; Calogero R; Curcio C; Bulfamante S; Brugiapaglia S; Cordero F; Novelli F;

Profiling small RNAs in fecal immunochemical tests: is it possible? in Molecular cancer / Mol Cancer. 2023 Oct 3;22(1):161. doi: 10.1186/s12943-023-01869-w.

2023
AOU Città della Salute di Torino

Birkeland E; Ferrero G; Pardini B; Umu SU; Tarallo S; Bulfamante S; Hoff G; Senore C; Rounge TB; Naccarati A;

Discovery of Targets for Cancer Immunoprevention. in Methods in molecular biology (Clifton, N.J.) / Methods Mol Biol. 2022;2435:19-33. doi: 10.1007/978-1-0716-2014-4_3.

2022
AOU Città della Salute di Torino

Cappello P; Bulfamante S; Mandili G; Novelli F;

The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. in Molecules (Basel, Switzerland) / Molecules. 2021 Mar 15;26(6):1642. doi: 10.3390/molecules26061642.

2021
AOU Città della Salute di Torino

Curcio C; Brugiapaglia S; Bulfamante S; Follia L; Cappello P; Novelli F;

In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001071. doi: 10.1136/jitc-2020-001071.

2020
AOU Città della Salute di Torino

Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F;

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners. in Cancers / Cancers (Basel). 2018 Feb 16;10(2):51. doi: 10.3390/cancers10020051.

2018
AOU Città della Salute di Torino

Cappello P; Curcio C; Mandili G; Roux C; Bulfamante S; Novelli F;

Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. in Journal of hematology & oncology / J Hematol Oncol. 2017 Jan 13;10(1):16. doi: 10.1186/s13045-016-0385-8.

2017
AOU Città della Salute di Torino

Principe M; Borgoni S; Cascione M; Chattaragada MS; Ferri-Borgogno S; Capello M; Bulfamante S; Chapelle J; Di Modugno F; Defilippi P; Nisticò P; Cappello P; Riganti C; Leporatti S; Novelli F;

Alpha-Enolase (ENO1), a potential target in novel immunotherapies. in Frontiers in bioscience (Landmark edition) / Front Biosci (Landmark Ed). 2017 Jan 1;22(5):944-959. doi: 10.2741/4526.

2017
AOU Città della Salute di Torino

Cappello P; Principe M; Bulfamante S; Novelli F;